Audentes Therapeutics, Inc. Common Stock, Value, Outstanding
Audentes Therapeutics, Inc. had Common Stock, Value, Outstanding of $402.00 million as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockValueOutstanding · last filed 2019-05-08
- 2019-03-31: Common Stock, Value, Outstanding $402.00M.
- 2018-12-31: Common Stock, Value, Outstanding $442.75M.
- 2018-03-31: Common Stock, Value, Outstanding $352.44M.
- 2017-12-31: Common Stock, Value, Outstanding $156.60M.
| Period end | Common Stock, Value, Outstanding |
|---|---|
| 2019-03-31 | $402.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $442.75M 10-Q · filed 2019-05-08 |
| 2018-03-31 | $352.44M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $156.60M 10-Q · filed 2019-05-08 |